Product Information
Registration Status: ActiveSIN01847P
ISOPRINOSINE TABLET 500mg is approved to be sold in Singapore with effective from 1988-06-16. It is marketed by UNITED ITALIAN TRADING CORPORATION PTE LTD, with the registration number of SIN01847P.
This product contains Methisoprinol 500mg in the form of TABLET. It is approved for ORAL use.
This product is manufactured by LABORATORIOS BARLY SA in COSTA RICA.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.
Indication
Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.
Mechanism of Action
Inosine pranobex stimulates cell-mediated immune processes to viral infections.
Pharmacokinetics
- Absorption
- Rapidly absorbed from GIT
- Distribution
- Metabolism
- Elimination
Toxicity
Mouse LD50 (Intravenous ): 1570 mg/kg Muse LD50 (Oral) : 9410mg/kg Mouse LD50 (subcutaneous) ; 2960mg/kg
Active Ingredient/Synonyms
IAD | Inosine acedobene dimepranol | Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3) | Inosiplex | Isoprinosine | Methisoprinol | Inosine pranobex |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.